Virax Biolabs Group Stock (NASDAQ:VRAX)


RevenueOwnershipFinancialsChart

Previous Close

$1.94

52W Range

$0.60 - $9.00

50D Avg

$2.67

200D Avg

$1.43

Market Cap

$7.64M

Avg Vol (3M)

$4.63M

Beta

1.98

Div Yield

-

VRAX Company Profile


Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

GB

Employees

17

IPO Date

Jul 21, 2022

Website

VRAX Performance


VRAX Financial Summary


Mar 23Mar 22Mar 21
Revenue$8.56K-$123.82K
Operating Income$-5.73M$-1.73M$-644.54K
Net Income$-5.46M$-1.71M$-650.98K
EBITDA$-5.73M$-1.73M$-644.54K
Basic EPS$-5.13$-1.50$-0.57
Diluted EPS$-5.13$-1.50$-0.57

Fiscal year ends in Mar 23 | Currency in USD

Peer Comparison


TickerCompany
BDRXBiodexa Pharmaceuticals Plc
BWVOnconetix, Inc.
KPRXKiora Pharmaceuticals, Inc.
PXMDPaxMedica, Inc. Common Stock
REVBRevelation Biosciences, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
HILSTharimmune, Inc.
ALLRAllarity Therapeutics, Inc.
NRBONeuroBo Pharmaceuticals, Inc.
UNCYUnicycive Therapeutics, Inc.
CDIOCardio Diagnostics Holdings, Inc.